Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 663

1.

Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger K, Blatter MM, Quataert SA, Madore DV, Chang I, Malinoski FJ, Hackell JG, Paradiso PR.

Pediatr Infect Dis J. 2001 Feb;20(2):153-9.

PMID:
11224833
[PubMed - indexed for MEDLINE]
2.

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.

Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B, Hackell J, Paradiso PR, Siber G, Kohberger R, Madore DV, Malinowski FJ, Kimura A, Le C, Landaw I, Aguilar J, Hansen J.

Pediatr Infect Dis J. 1999 Sep;18(9):757-63.

PMID:
10493334
[PubMed - indexed for MEDLINE]
3.

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA, Madore DV, Chang I, Paradiso PR, Malinoski FJ, Kimura A.

Pediatrics. 1998 Apr;101(4 Pt 1):604-11.

PMID:
9521941
[PubMed - indexed for MEDLINE]
4.

Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.

Campagne G, Garba A, Fabre P, Schuchat A, Ryall R, Boulanger D, Bybel M, Carlone G, Briantais P, Ivanoff B, Xerri B, Chippaux JP.

Pediatr Infect Dis J. 2000 Feb;19(2):144-50.

PMID:
10694002
[PubMed - indexed for MEDLINE]
5.

Safety and immunogenicity of CRM197-conjugated pneumococcal-meningococcal C combination vaccine (9vPnC-MnCC) whether given in two or three primary doses.

Sigurdardottir ST, Davidsdottir K, Arason VA, Jonsdottir O, Laudat F, Gruber WC, Jonsdottir I.

Vaccine. 2008 Aug 5;26(33):4178-86. doi: 10.1016/j.vaccine.2008.05.072. Epub 2008 Jun 17.

PMID:
18606481
[PubMed - indexed for MEDLINE]
6.

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.

Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S77-88. doi: 10.1097/INF.0b013e318199f609.

PMID:
19325450
[PubMed - indexed for MEDLINE]
7.

Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants.

Rennels M, King J Jr, Ryall R, Papa T, Froeschle J.

Pediatr Infect Dis J. 2004 May;23(5):429-35.

PMID:
15131466
[PubMed - indexed for MEDLINE]
8.

Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial.

MacLennan JM, Shackley F, Heath PT, Deeks JJ, Flamank C, Herbert M, Griffiths H, Hatzmann E, Goilav C, Moxon ER.

JAMA. 2000 Jun 7;283(21):2795-801.

PMID:
10838647
[PubMed - indexed for MEDLINE]
9.

Relationship between serum bactericidal activity and serogroup-specific immunoglobulin G concentration for adults, toddlers, and infants immunized with Neisseria meningitidis serogroup C vaccines.

Sikkema DJ, Friedman KE, Corsaro B, Kimura A, Hildreth SW, Madore DV, Quataert SA.

Clin Diagn Lab Immunol. 2000 Sep;7(5):764-8.

PMID:
10973451
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants.

Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K.

J Infect Dis. 1996 Dec;174(6):1360-3.

PMID:
8940235
[PubMed - indexed for MEDLINE]
Free Article
11.

Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children.

McVernon J, Maclennan J, Buttery J, Oster P, Danzig L, Moxon ER.

Pediatr Infect Dis J. 2002 Aug;21(8):747-53.

PMID:
12192163
[PubMed - indexed for MEDLINE]
12.

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

Anderson EL, Bowers T, Mink CM, Kennedy DJ, Belshe RB, Harakeh H, Pais L, Holder P, Carlone GM.

Infect Immun. 1994 Aug;62(8):3391-5.

PMID:
8039909
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants.

Nurkka A, Joensuu J, Henckaerts I, Peeters P, Poolman J, Kilpi T, Käyhty H.

Pediatr Infect Dis J. 2004 Nov;23(11):1008-14.

PMID:
15545855
[PubMed - indexed for MEDLINE]
14.

Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.

Morley SL, Cole MJ, Ison CA, Camaraza MA, Sotolongo F, Anwar N, Cuevas I, Carbonero M, Campa HC, Sierra G, Levin M.

Pediatr Infect Dis J. 2001 Nov;20(11):1054-61.

PMID:
11734711
[PubMed - indexed for MEDLINE]
15.

A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

Twumasi PA Jr, Kumah S, Leach A, O'Dempsey TJ, Ceesay SJ, Todd J, Broome CV, Carlone GM, Pais LB, Holder PK, et al.

J Infect Dis. 1995 Mar;171(3):632-8.

PMID:
7876610
[PubMed - indexed for MEDLINE]
16.

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.

MacDonald NE, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM.

JAMA. 1998 Nov 18;280(19):1685-9.

PMID:
9832000
[PubMed - indexed for MEDLINE]
17.

A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge phase.

Riddell A, Buttery JP, McVernon J, Chantler T, Lane L, Bowen-Morris J, Diggle L, Morris R, Lockhart S, Pollard AJ, Cartwright K, Moxon ER.

Vaccine. 2007 May 10;25(19):3906-12. Epub 2007 Feb 7.

PMID:
17368663
[PubMed - indexed for MEDLINE]
18.

Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines.

Wysocki J, Tansey S, Brachet E, Baker S, Gruber W, Giardina P, Arora A.

Vaccine. 2010 Nov 16;28(49):7779-86. doi: 10.1016/j.vaccine.2010.09.047. Epub 2010 Sep 28.

PMID:
20883736
[PubMed - indexed for MEDLINE]
19.

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.

Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S109-18. doi: 10.1097/INF.0b013e318199f62d. Review.

PMID:
19325447
[PubMed - indexed for MEDLINE]
20.

Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age.

Tejedor JC, Moro M, Merino JM, Gómez-Campderá JA, García-del-Rio M, Jurado A, Díez-Delgado FJ, Omeñaca F, García-Sicilia J, Ruiz-Contreras J, Martin-Ancel A, Roca J, Boceta R, García-Corbeira P, Maechler G, Boutriau D; Spanish 102547 Study Group.

Pediatr Infect Dis J. 2008 Jul;27(7):579-88. doi: 10.1097/INF.0b013e31816b4561.

PMID:
18536619
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk